David J. Elliott

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis”.

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

The Lancet Oncology(2021)10.1016/s1470-2045(20)30730-0

N/A

0DataRank · unranked

112 citations

Ralph Jiang, David G. Wallington, Gavin Jones, Samuel R. Birer, Neil Jairath +20 more

Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer

Lung Cancer(2021)10.1016/j.lungcan.2021.11.021

N/A

0DataRank · unranked

36 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Angel Qin +4 more

Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100707

N/A

0DataRank · unranked

8 citations

Rachel Lipson, Matthew Johnson, Christina D. Williams, Drew Moghanaki, David J. Elliott +5 more

A de novo paradigm for male infertility

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.27.433155

N/A

0DataRank · unranked

1 citations

RM Smits, H E Smith, FK Mastrorosa, GS Holt, BJ Houston +35 more

A de novo paradigm for male infertility

Nature Communications(2022)10.1038/s41467-021-27132-8

N/A

0DataRank · unranked

99 citations

RM Smits, H E Smith, Francesco Mastrorosa, Giles Holt, Brendan J. Houston +59 more

Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.03.015

N/A

0DataRank · unranked

21 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, Victoria Daniel, David J. Elliott +3 more

Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2021.12.176

N/A

0DataRank · unranked

19 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Victoria Daniel +3 more

Cannabis Use in Patients Seen in an Academic Radiation Oncology Department

Practical Radiation Oncology(2022)10.1016/j.prro.2022.11.002

N/A

0DataRank · unranked

10 citations

Chuck Mayo, Theresa P. Devasia, Michael Dykstra, S.N. Regan, Sean R. Miller +20 more

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Research Square(2022)10.21203/rs.3.rs-2092111/v1

N/A

0DataRank · unranked

1 citations

Emma Scott, Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung +54 more

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Oncogene(2023)10.1038/s41388-023-02604-x

N/A

0DataRank · unranked

74 citations

Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung, Abel Bermudez +54 more

Replicating the timing of androgen deprivation therapy randomized trial (TROG 03.06 and VCOG PR 01-03 [TOAD]) for recurrent prostate cancer using real-world observational data.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e17090

N/A

0DataRank · unranked

0 citations

Daniel J. Herr, David J. Elliott, Gillian Duchesne, Jennifer Burns, Jordan B. Sparks +5 more